DJIA 17,279.74 13.75 0.08%
NASDAQ 4,579.79 -13.64 -0.30%
S&P 500 2,010.40 -0.96 -0.05%
market minute promo

Accuray, Inc. (NASDAQ: ARAY)

7.95 -0.15 (-1.85%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

ARAY $7.95 -1.85%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $8.13
Previous Close $8.10
Daily Range $7.85 - $8.14
52-Week Range $6.46 - $10.85
Market Cap $614.5M
P/E Ratio -17.23
Dividend (Yield) $0.00 (0.0%)
Volume 874,052
Average Daily Volume 859,894
Current FY EPS -$0.22

Sector

Healthcare

Industry

Healthcare Information Services

Accuray, Inc. (ARAY) Description

The Company has developed the commercially available intelligent robotic radiosurgery system, the CyberKnife system, designed to treat solid tumors anywhere in the body as an alternative to traditional surgery. Website: http://www.accuray.com/

News & Commentary

Will Obamacare Lead to a Medical Device Innovation Revolution?

Obamacare was expected to weigh heavily on the medical device sector, but the end result may surprise you!

Accuray Signs CyberKnife and TomoTherapy Systems Deal - Analyst Blog

Accuray Signs CyberKnife and TomoTherapy Systems Deal - Analyst Blog

Zacks Rank #5 Additions for Monday - Tale of the Tape

Can 'Blocking And Tackling' Lead Accuray Higher?

Accuray Fiscal Q4 Loss Wider than Expected but Narrower Y/Y - Analyst Blog

Accuray Fiscal Q4 Loss Wider than Expected but Narrower Y/Y - Analyst Blog

Accuray's (ARAY) CEO Josh Levine on Q4 2014 Results - Earnings Call Transcript

Accuray Incorporated (ARAY) Q2 2014 Results - Earnings Call Webcast

Earnings Scheduled For August 21, 2014

Cepheid's Diagnostic Test Menu Expansion to Fend Competition - Analyst Blog

Mindray Medical Beats Q2 Earnings by a Penny, Cuts 2014 View - Analyst Blog

Sirona Dental Systems Q3 Earnings & Revenues Beat Estimates - Analyst Blog

See More ARAY News...

ARAY's Top Competitors

ARAY $7.95 (-1.85%)
Current stock: ARAY
$0.00 (0.00%)
Current stock:
MDT $66.22 (-0.47%)
Current stock: MDT
COV $90.85 (-0.82%)
Current stock: COV